Hypogonadotroper Hypogonadismus aufgrund eines IHH oder Kallmann-Syndroms beim Mann

Behre HM, Nieschlag E, Partsch CJ et al (2009) Störungen im Bereich des Hypothalamus und der Hypophyse. In: Nieschlag E, Behre HM, Nieschlag S (Hrsg) Andrologie – Grundlagen und Klinik der reproduktiven Gesundheit des Mannes. Springer, Berlin, S 175–198

Beranova M, Oliveira LM, Bedecarrats GY et al (2001) Prevalence, phenotypic spectrum and modes of inheritance of gonadotropin-releasing hormone receptor mutations in idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 86:1580–1588

Bianco S, Kaiser UB (2009) The genetic and molecular basis of idiopathic hypogonadotropic hypogonadism. Nat Rev Endocrinol 5:569–576

Bouloux P, Warne DW, Loumaye E; FSH Study Group in Men’s Infertility (2002) Efficacy and safety of recombinant human follicle-stimulating hormone in men with isolated hypogonadotropic hypogonadism. Fertil Steril 77:270–273

Büchter D, Behre HM, Kliesch S, Nieschlag E (1998) Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases. Eur J Endocrinol 139:298–303

Caron P, Chauvin S, Christin-Maitre S et al (1999) Resistance of hypogonadic patients with mutated GnRH receptor genes to pulsatile GnRH administration. J Clin Endocrinol Metab 84:990–996

Caronia LM, Martin C, Welt CK et al (2011) A genetic basis for functional hypothalamic amenorrhea. N Engl J Med. 364:215–225

Chan YM, Guillebon A de, Lang-Muritano M et al (2009) GNRH1 mutations in patients with idiopathic hypogonadotropic hypogonadism. PNAS 106:11703–11709

Cooper TG, Noonan E, Eckardstein S von et al (2010) World Health Organization reference values for human semen characteristics. Hum Reprod Update 16:231–245

Coutant R, Biette-Demeneix E, Bouvattier C et al (2010) Baseline inhibin B and anti-Mullerian hormone measurements for diagnosis of hypogonadotropic hypogonadism (HH) in boys with delayed puberty. J Clin Endocrinol Metab 95:5225–5232

Dode C, Texeira L, Levilliers J et al (2006) Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2. PLoS Genet 2(19):e175. Epub

Dwyer AA, Hayes FJ, Plummer L et al (2010) The long-term clinical follow-up and natural history of men with adult-onset idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 95:4235–4243

Falardeau J, Chung WC, Beenken A et al (2008) Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice. J Clin Invest 118:2822–2831

Han TS, Bouloux PM (2010) What is the optimal therapy for young males with hypogonadotropic hypogonadism? Clin Endocrinol (Oxf) 72:731–737

Kaplan JD, Bernstein JA, Kwan A, Hudgins L (2010) Clues to an early diagnosis of Kallmann syndrome. Am J Med Genet A 152A:2796–2801

Kim HG, Kurth I, Lan F et al (2008) Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. Am J Hum Genet 83:511–519

Kim HG, Ahn JW, Ullmann R et al (2010) WDR11, a WD protein that interacts with transcription factor EMX1, is mutated in idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. Am J Hum Genet 87:465–479

Lanfranco F, Gromoll J, Eckardstein S von et al (2005) Role of sequence variations of the GnRH receptor and G protein-coupled receptor 54 gene in male idiopathic hypogonadotropic hypogonadism. Eur J Endocrinol 153:845–852

Liu PY, Baker HW, Jayadev V et al (2009) Induction of spermatogenesis and fertility during gonadotropin treatment of gonadotropin-deficient infertile men: predictors of fertility outcome. J Clin Endocrinol Metab 94:801–808

Miura K, Acierno JS, Seminara SB (2004) Characterization of the human nasal embryonic LHRH factor gene, NELF, and a mutation screening among 65 patients with idiopathic hypogonadotropic hypogonadism (IHH). J Hum Genet 49:265–268

Montague CT, Farooqi S, Whitehead FP et al (1997) Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387:903–908

Pallais JC, Au M, Pitteloud N et al (2011) Kallmann Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K (Hrsg) GeneReviews [Internet]. University of Washington, Seattle/WA, updated 04 Jan 2011

Raivio T, Falardeau J, Dwyer A et al (2007) Reversal of idiopathic hypogonadotropic hypogonadism. N Engl J Med 357:863–873

Schwanzel-Fukuda M, Bick D, Pfaff DW (1989) Luteinizing hormone-releasing hormone (LHRH)-expressing cells do not migrate normally in an inherited hypogonadal (Kallmann) syndrome. Mol Brain Res 6:311–326

Seminara SB, Hayes FJ, Crowley WF Jr (1998) Gonadotropin-releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmann’s syndrome): pathophysiological and genetic considerations. Endocr Rev 19(5):521–539

Spratt DI, Carr DB, Merriam GR et al (1987) The spectrum of abnormal patterns of gonadotropin-releasing hormone secretion in men with idiopathic hypogonadotropic hypogonadism: clinical and laboratory correlations. J Clin Endocrinol Metab 64:283–291

Sykiotis GP, Plummer L, Hughes VA et al (2010) Oligogenic basis of isolated gonadotropin-releasing hormone deficiency. PNAS 107:15140–15144

Sykiotis GP, Hoang XH, Avbelj M et al (2010) Congenital idiopathic hypogonadotrophic hypogonadism: evidence of defects in the hypothalamus, pituitary, and testes. J Clin Endocrinol Metab. 95:3019–3027

Warne DW, Decosterd G, Okada H et al (2009) A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin. Fertil Steril 92:594–604

Young J, Bouligand J, Francou B et al (2010) TAC3 and TACR3 defects cause hypothalamic congenital hypogonadotropic hypogonadism in humans. J Clin Endocrinol Metab 95:2287–2295